Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool. - Wikidata - wikimedia - TriplyDB

Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool.

Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool.

http://www.wikidata.org/entity/Q42196037

about

Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015 HIV-1 drug resistance and resistance testing.HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp Field study of dried blood spot specimens for HIV-1 drug resistance genotyping Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda Early immune adaptation in HIV-1 revealed by population-level approaches.Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada HIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patients HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by a near-full-genome population and deep sequencing approaches.Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries.Determinants of virological failure and antiretroviral drug resistance in Mozambique.Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study.HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.Identification of major routes of HIV transmission throughout Mesoamerica.Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis.Development and Validation of Two Screening Assays for the Hepatitis C Virus NS3 Q80K Polymorphism Associated with Reduced Response to Combination Treatment Regimens Containing Simeprevir

P2860

Q28534497-BBC18773-204E-488F-85C9-F2F0B32EA611 Q28543688-65DD43F8-DC00-401D-9231-9109437BBBA4 Q28554725-CC5928C5-6245-4072-905B-71FE3C181EF8 Q30245693-93C06C0F-916F-4FE5-B129-177ADE37D692 Q33669836-1BAA4171-F5B6-4951-9B2B-F2B9BEEDD058 Q33721466-9FA1AE10-6B79-4D4C-9990-918D4E00797F Q33742478-B16F730A-30BA-4DB1-82AD-337FCF9B7F29 Q34058841-A4533B36-E43D-4CE1-83EC-C33008F02B31 Q34116836-EAB913AC-281E-4989-BBBC-1C9C58C4BCB5 Q34308788-CAAA438E-CD09-4A17-A4D0-D64C10CC3035 Q34415820-4E6F353A-7BA0-4E5D-B643-A8E8A8E29DAE Q34508492-734988AD-AC9F-4E34-BB25-93E59B18F3F9 Q34781706-780D8279-13D2-4EB6-9B06-E23F6C751F40 Q34975934-40A44326-521D-4C0E-93FD-620CAECBE359 Q35156765-E27B1225-1100-4C47-B6D6-15E845A69055 Q36032235-54DB41F0-92EB-4A71-98FB-1384EA50BC85 Q36120059-B33E2E0B-1A28-4A7B-B5AE-91BC69FA47F6 Q36158371-EC2F20AA-0F76-47F9-A734-75D705E56001 Q36274049-7BC2EBF2-1BDA-4BA2-A221-5AB28F702C32 Q36343848-EBFF9931-EF75-4185-A96F-603FD50D4DCB Q36414604-7A3A490D-3DF3-4E47-B931-7CA46467BBCA Q36418462-E7FA25FF-6BEF-43A2-B4A0-B9DCCCA317E4 Q36481449-C48AEE96-E700-4A4E-8E45-192074BB98E0 Q36506119-B6A64C19-12E9-46B2-B630-D5066A66F826 Q36922133-240DDA6F-407A-4D0A-989A-3EDA3293D52F Q37005868-0416F758-19CF-4C0F-A6AE-AB8802DD7C1E Q37048027-15A9AA46-E9B4-419C-A603-A0510D2C1F90 Q37094767-9D1C7EEC-AEA1-498C-AFCB-8F8919E39B99 Q37547823-B9A06433-EB2B-475F-9816-07032064BB44 Q38612752-F2E4CE20-B4E2-43E7-BD33-186275060385 Q38738833-98117C7C-64EE-4A66-83DD-08A3290962A5 Q38963716-7DAA9815-59D4-4610-BFAD-0C73F9CF954D Q39149710-DC4EAB8E-AF51-4835-8215-520281AB1D75 Q39414398-C5C05CA9-656B-41FD-89B8-444617B4F9F4 Q39536633-80E43F04-FCD5-43EE-B8C4-D1F11B98FC91 Q39835202-ED97EEA4-6098-4EF2-B813-8C772AA94310 Q40118634-AE3A247A-C3E4-4377-95EA-873002AE7114 Q40147603-F00EE55F-C0BA-445D-89A4-DEAD67715FD4 Q40796505-89F259D5-FF4B-4185-BBC0-35BAAA2F8D43 Q41127462-D71863CE-E024-4B28-A47A-2FE3AE5BF1BE

P2860

Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool.

http://www.wikidata.org/entity/Q42196037

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Automating HIV drug resistance ...... ssible sequence analysis tool.

@en

Automating HIV drug resistance ...... ssible sequence analysis tool.

@nl

type

label

Automating HIV drug resistance ...... ssible sequence analysis tool.

@en

Automating HIV drug resistance ...... ssible sequence analysis tool.

@nl

prefLabel

Automating HIV drug resistance ...... ssible sequence analysis tool.

@en

Automating HIV drug resistance ...... ssible sequence analysis tool.

@nl

P1433

Q42196037-4F1A4664-B038-4C52-98CA-546CBA32D287

P1476

Q42196037-FF699EC8-9FFA-4F30-8912-D8EE695CD3F5

P2093

Q42196037-0061D855-F726-467F-83DC-31178AB0CD03

Q42196037-1703200F-6565-4FA7-88D1-51517CD8C8E2

Q42196037-716DDC5B-7E78-4BA3-99B6-81825ECC30F3

Q42196037-82E23ACC-A1CB-40A3-A8DB-8FE57A887445

Q42196037-8CA864A8-3A20-447D-BFD6-73A545D80634

Q42196037-9498C4E0-D510-4903-B04B-802B0BCB06B9

Q42196037-AFE30B6F-F19B-45CB-992E-E3ED70381F69

Q42196037-BB48173C-A587-458B-AFB3-3754F93EEC18

Q42196037-E3152695-5D5B-4F35-80FB-962BB6CAA740

P2860

Q42196037-0978137C-09ED-49D9-B568-2BD20C943EA2

Q42196037-1D3A6CFD-DFAB-4642-A326-84896925ED9B

Q42196037-2E2DADDB-CCCD-4F4A-AF6A-122E663E4B4D

Q42196037-31682AB6-730F-4C11-8F97-6A4856BDFCEE

Q42196037-47388F5A-659E-4301-BCDE-ED0546A6341B

Q42196037-608355A1-CD01-4B0B-BF4A-CAE5EBDE3211

Q42196037-8C816E1E-956C-47E7-B924-847788491C81

Q42196037-A7E75D13-CF4F-4D4E-A89B-6EB91292BA0D

Q42196037-ACCA6D1C-897B-4674-B69F-31F82AA784E8

Q42196037-B39DAF64-F380-4F98-A688-C80858FA8B2A

P304

Q42196037-E10C110A-AA13-4191-92B3-50E409EF27A8

P31

Q42196037-AB897D41-E98A-4261-9980-D66AB4AEFC9E

P356

Q42196037-D3C4169F-DA28-4444-ABEB-7B62A882B59C

P407

Q42196037-02E9E45A-889C-4138-9560-271A00FCC395

P433

Q42196037-3FE33C9E-1288-415E-A00F-CC9E8E42ED79

P478

Q42196037-757C35DE-DED2-412B-AE0A-FFAE79E6E521

P50

Q42196037-5773882B-F286-4B3F-B772-FCCA5E8E7373

P577

Q42196037-5B3D613D-B0A8-4994-A8DA-C5F1E920C23D

P698

Q42196037-94594B35-7B96-4975-B0BA-341D1512C941

P921

Q42196037-0D79859E-E6F0-4DC0-A5B1-B0430FA6597B

P932

Q42196037-BD757830-44C0-43C9-9B32-3A3C9F695CC0

P356

P1433

Journal of Clinical Microbiology

P1476

Automating HIV drug resistance ...... ssible sequence analysis tool.

@en

P2093

Anna L Chu

http://www.w3.org/2001/XMLSchema#string

Brian Wynhoven

http://www.w3.org/2001/XMLSchema#string

Celia K S Chui

http://www.w3.org/2001/XMLSchema#string

Christina Trevino

http://www.w3.org/2001/XMLSchema#string

Conan K Woods

http://www.w3.org/2001/XMLSchema#string

P Richard Harrigan

http://www.w3.org/2001/XMLSchema#string

Robert W Shafer

http://www.w3.org/2001/XMLSchema#string

Tom A Hall

http://www.w3.org/2001/XMLSchema#string

Tommy F Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Base-calling of automated sequencer traces using phred. II. Error probabilities

Base-calling of automated sequencer traces using phred. I. Accuracy assessment

Identification of common molecular subsequences

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.

Genetic methods for assessing antimicrobial resistance.

Accuracy of the TRUGENE HIV-1 genotyping kit.

Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.

Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.

Web resources for HIV type 1 genotypic-resistance test interpretation.

P304

1936-1942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.06689-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Chanson J Brumme

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22403431

http://www.w3.org/2001/XMLSchema#string

P921

P932

3372133

http://www.w3.org/2001/XMLSchema#string